(Date:1/8/2009)...MDS Inc. (TSX: MDS; NYSE: MDZ ), a leading provi...iences markets, today reported its final fourth-qu...-end audit for the period ended October 31, 2008. ... 2008, MDS reported total revenue of $322 million....ll write-down, previously estimated to be in the r...
(Date:1/8/2009)...tCall/ -- Cardinal Health today,announced it expe...ts for its,fiscal second quarter, but provided ca...e of a deferral in hospital capital spending affec..., Non-GAAP diluted EPS from continuing opera... ended Dec. 31, 2008, is anticipated to be at leas...
(Date:1/8/2009)...come Organ Donors and Provide the Gift of Life , ...ff Timmons, the founder of the pop band 98 Degrees... all of his fans - sign up today to become organ d... http://www.newscom.com/cgi-bin/prnh/20090108/NY56... the newly formed Heather Trew Foundation, Timmons...
(Date:1/8/2009)...Call/ -- Elsevier, the leading,publisher of medic... it,renewed its publishing partnership with the A...acc.org ), the leading nonprofit medical society i...ment calls for Elsevier to publish,the society,s ...of Cardiology,(JACC) ( http://www.elsevier.com/l...
Breaking Medicine News(10 mins):Health News:MDS Reports Final Fourth-Quarter 2008 Results 2Health News:MDS Reports Final Fourth-Quarter 2008 Results 3Health News:MDS Reports Final Fourth-Quarter 2008 Results 4Health News:Cardinal Health Updates FY09 Outlook 2Health News:Cardinal Health Updates FY09 Outlook 3Health News:Cardinal Health Updates FY09 Outlook 4Health News:Cardinal Health Updates FY09 Outlook 5Health News:Jeff Timmons and the Heather Trew Foundation Join Forces to Promote Organ Donations 2Health News:The American College of Cardiology Renews its Publishing Partnership With Elsevier 2Health News:The American College of Cardiology Renews its Publishing Partnership With Elsevier 3(Date:1/7/2009)...ire-FirstCall/ -- Eli Lilly and Company,(NYSE: ...response letter from,the U.S. Food and Drug Admin...ion (LAI) for acute and maintenance treatment of s...rk with the agency on the new drug,application (N...nal clinical trials for the continued,review of t...
(Date:1/7/2009)...e/ -- ImQuest Life Sciences announced today the su...ood and Drug Administration to initiate human clin...ibitor IQP-0410. ImQuest anticipates initiating th...IQP-0410 is a novel small molecule inhibitor of HI...transcriptase inhibitor (NNRTI). The compound poss...
(Date:1/7/2009)...RNewswire/ -- Circassia Ltd, a specialty,biopharm...care, today,announced that following successful c...une(R) anti-allergy technology, the company has no...se II clinical trial in cat allergy. The,study, w...ents with confirmed,cat allergies, and all the pa...
(Date:1/6/2009).../ -- In recent controlled studies conducted by Dr....sts found that the patented ingredient in Glyc,n G...ingredient to increase levels of nitric oxide (NO)...rate (NOx) in human subjects. , , Nitric oxide ...lood flow to the skeletal muscles. This is signif...
Breaking Medicine Technology:FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 2FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 3FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 4FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 5FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 6ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2Environmental Tectonics Corporation Announces Sale of Two Hyperbaric Monoplace Chambers 19708 1Environmental Tectonics Corporation Announces Sale of Two Hyperbaric Monoplace Chambers 19708 2Environmental Tectonics Corporation Announces Sale of Two Hyperbaric Monoplace Chambers 19708 3Environmental Tectonics Corporation Announces Sale of Two Hyperbaric Monoplace Chambers 19708 4Direct Medical Systems Reaches Profitability in 2 1 2 Years as a Result of Sales of the Worlds Smallest and Lightest Ultrasound System the InNovaSou 5495 1Direct Medical Systems Reaches Profitability in 2 1 2 Years as a Result of Sales of the Worlds Smallest and Lightest Ultrasound System the InNovaSou 5495 2RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer 2111 1RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer 2111 2RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer 2111 3RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer 2111 4RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer 2111 5RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer 2111 6Drug brings relief for many IBS patients who experience constipation 19697 1Drug brings relief for many IBS patients who experience constipation 19697 2..., 2007 - Synthetic Blood,International, Inc. (OTCB...stical analysis of its Phase IIa study with Oxycyt...line with preliminary,study results announced in D...he primary endpoint of increasing patients, oxygen...ta also show a,decrease in patient glucose and lac...
...ast 45% additional,reduction in patients, LDL-chol...wering therapies, CARLSBAD, Calif., May 17, 2007 /.... announced updated results from its ongoing,Phase...homozygous,familial hypercholesterolemia (HoFH), i... the of Cardiology Annual Scientific Session,(ACC)...
Other Medicine Technology:Positive Statistical Analysis from Synthetic Blood's Oxycyte,Traumatic Brain Injury Trial Indicates Achievement of Primary,Endpoint 2Positive Statistical Analysis from Synthetic Blood's Oxycyte,Traumatic Brain Injury Trial Indicates Achievement of Primary,Endpoint 3Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 2Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 3Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 4Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 5...mera systems for qualified microscopic documentati...ith images of highest color fidelity, resolution a...s can rely on access to perfect images due to the ...nnovative readout modes make this camera the best ...
The U-III's compact, sleek design and advanced exposure system with multi-point sensor, make it the system of choice for serious fluorescence applications including FISH. It is ideal for use at resea
The DS-5M-L1 consists of a 5-megapixel color matrix CCD for high resolution and breathtaking colors, camera control unit with a full range of features, including a crystal clear LCD display monitor.
This compact photomicrographic system assures simple operation to achieve the exposure accuracy required for sophisticated photomicrography in most research and clinical environments.
Medicine Products: